scnd_8k.htm

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________________________

 

FORM 8-K

_________________________________________________

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):November 4, 2022

_________________________________________________

 

SCIENTIFIC INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-6658

 

04-2217279

(State or other Jurisdiction)

 

(Commission File Number)

 

(IRS Employer No.)

 

80 Orville Drive

Bohemia, New York 11716

__________________________________________________

(Address of principal executive offices)

 

(631) 567-4700

__________________________________________________

(Registrant's telephone number, including area code)

 

Not Applicable

__________________________________________________

(Former name or former address, if changed since last report)

 

 

 

  

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. 

 

On November 4, 2022, the Board of Directors, approved to change the Company’s fiscal year end from June 30 of each year to December 31 of each year. In accordance with the applicable rules of the Securities Exchange Act of 1934, as amended, the Company will file, on or about March 31, 2023, a transition report on Form 10-K with respect to the six-month transition period beginning July 1, 2022 and ending December 31, 2022. The Company’s 2023 fiscal year will commence on January 1, 2023.

 

ITEM 9.01 Financial Statements and Exhibits

 

(a),(b),(c) not applicable

 

(d) Exhibits

 

 

Exhibit No

 

Description

 

 

 

3.1

 

Third Amended and Restated Bylaws

 

 
2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

SCIENTIFIC INDUSTRIES, INC.

 

 

 

 

Date: November 9, 2022

By:

/s/ Helena R. Santos

 

 

 

Helena R. Santos,

 

 

 

President and Chief Executive Officer

 

 

 
3